Upside Biotechnologies is in the process of developing what it believes to be, advanced and effective treatment for burn victims. The product, known as PelliCel® is a regenerative medicine solution for burn victims. PelliCel® works by growing multiple sheets of differentiated, grantable skin of the patents in order to cover burns.
Upside PelliCel® is produced faster than any other competitor in the product range giving it a strong market advantage. Students who are accepted to this role will be given the opportunity to experience a variety of the business elements from development right through to the sales of the product and see how the end product changes lives.
Upside Biotechnologies aims to initiate the first clinical trial of PelliCel® in 2020.
For more information, please click here.